Ann: Successful OHD Cereal Crop Trials, page-666

First 666 Last

Share
Profile

Follow
Davy Boy

16,495 Posts.

3924

28/08/17

22:08

Post #: 26819841
Share

Originally posted by fooca ↑

I actually don't believe that people think we have an open ended licence agreement for anything that can be produced using the OHD process... point in reference, GP's announcement actually only stipulates Bio Stimulants but unless we could actually see the licence itself we will have to just agree to disagree.

View attachment 703815
http://www.asx.com.au/asxpdf/20170512/pdf/43j6pvvqh9tdhg.pdf

To further support why I think it is only for the bio stimulant and not what ever can be produced are:
Assuming that the 4th unit would be required to make the platform chemicals, then how on earth could Thermaquatica grant a licence for something they don't hold the patent to as yet?
As well as granting a licence for something not proven either?

quote:
Interestingly Thermaquatica have a patent pending for unit op 4 and this may well be the cause of the delay. AIMO DB
post:26805201

As the world's major car manufacturers move to cease production of ICE's, and move toward clean energies re: electric vehicles etc, why would GPP want to make a Bio Diesel, would we have a market for it?
Assuming
1: We actually had a plant
2: That plant had the required added on modules to make it (and proven)
quote:
I wonder how much a litre GPP can produce bio diesel for? Has anyone done any research around this? TIA DB
post:26811795

Just FYI
The same announcement did also say that the granting of the licence was key to the finalising of the PFS which is now the Commercial Plan, pfffffft.

PS: These questions will be added to the list when GPP management can get around to answering my email.

cheers

Expand

Hi Fooca.
Process 4 has a patent pending.....that does not mean there are not other technologies/methods that can be used to produce the chemicals..... Sneddon outlined them.
From this link c/o Non.
http://www.asx.com.au/asxpdf/20160509/pdf/4373mn8sbmn0tq.pdf

Lastly as far as I can see Sneddon hardly mentions bio stimulant if at all.
Why would they commission a report for a licence they don't have? Answer....they wouldn't. DB

GPP Price at posting: 1.4¢ Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

CHN

Chalice jumps on Putin nickel export ban threat – but then there's bad news

3 stocks with antimony news on Thursday

DXB

Dimerix begins recruiting young kidney disease patients in Mexico for Phase 3

GTR

GTI extends uranium mineralisation at Lo Hema through development drilling

CU6

Clarity progresses SECuRE trial with positive safety results